Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Certain hormone treatments can improve acne and related conditions in women.

Oral contraceptives and antiandrogens are the best treatments for hirsutism.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Birth control pills can help reduce mild to moderate acne in women.

Non-surgical treatments can significantly reduce keloids in children, with combination therapies being safer and more effective.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Hirsutism, excessive hair growth in women, is often caused by polycystic ovarian syndrome and is treated by targeting the cause, lifestyle changes, and medication.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Choose oral contraceptives with specific side effects to manage issues like acne and avoid unwanted effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Hormonal therapies are safe and effective for treating adult women's acne.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.